--- title: "The brain-computer interface sector continues to strengthen, DNAKE hits the 20% daily limit up" type: "News" locale: "en" url: "https://longbridge.com/en/news/238822261.md" description: "The brain-computer interface sector continues to strengthen, DNAKE hits a 20% limit up, APON rises over 7%, CTN, Innovative Medical, Stonehill Technology, and Sanbo Neuroscience follow suit" datetime: "2025-05-06T02:01:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/238822261.md) - [en](https://longbridge.com/en/news/238822261.md) - [zh-HK](https://longbridge.com/zh-HK/news/238822261.md) generator: "portal-rs" --- # The brain-computer interface sector continues to strengthen, DNAKE hits the 20% daily limit up The brain-computer interface sector continues to strengthen, with DNAKE hitting the 20% daily limit, APON rising over 7%, and CTN, Innovative Medical, Stonehill Technology, and Sanbo Neuroscience following suit ### Related Stocks - [002173.CN](https://longbridge.com/en/quote/002173.CN.md) - [300753.CN](https://longbridge.com/en/quote/300753.CN.md) - [300884.CN](https://longbridge.com/en/quote/300884.CN.md) - [300430.CN](https://longbridge.com/en/quote/300430.CN.md) - [002195.CN](https://longbridge.com/en/quote/002195.CN.md) - [301293.CN](https://longbridge.com/en/quote/301293.CN.md) ## Related News & Research - [Orkla trims ORK89 bond holdings to boost market float](https://longbridge.com/en/news/298495215.md) - [Polaris Media Takes Full Ownership of Polaris Media Sør in NOK 450 Million Deal](https://longbridge.com/en/news/298473435.md) - [CaMaRa launches with seed financing backed by Forbion, Novo Holdings, NEA and RA Capital](https://longbridge.com/en/news/298465178.md) - [Northern Ocean mandatory offer at NOK 7.5 per share closes Sept. 9, no extension](https://longbridge.com/en/news/298424562.md) - [EWG: Double-digit revenue growth and digital platform adoption drive robust margins and returns](https://longbridge.com/en/news/298417346.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**